HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pinacidil-induced opening, like glibenclamide-induced closure of cardiac KATP channels, protects cardiac function against ischemia in isolated, working, erythrocyte perfused rat hearts.

Abstract
Glibenclamide-induced closure of ATP-dependent potassium (KATP) channels decreases coronary blood flow during normoxic and post-ischemic conditions. We have found that post-ischemic cardiac function is improved after glibenclamide treatment. Our theory was that this is a result of higher intracellular calcium concentrations due to reduction in ischemia-mediated hyperpolarization of the myocardial cell membrane. We hypothesized therefore that opening KATP channels would reduce post-ischemic function in our isolated, erythrocyte perfused, working rat heart model. During treatment with 1 or 12 mumol.L-1 pinacidil (protein unbound concentration) both before and after 12 minutes global ischemia coronary blood flow increased 2-3 fold compared with vehicle, while cardiac functional recovery post-ischemically was improved with both concentrations. Because closing and opening cardiac KATP channels both improve post-ischemic function, our calcium theory above can be discounted. The protective effect of glibenclamide may possibly be ascribed to metabolic effects such as preservation of ATP levels during ischemia.
AuthorsRoger J Legtenberg, Ralph J Houston, Paul Smits, Berend Oeseburg
JournalAdvances in experimental medicine and biology (Adv Exp Med Biol) Vol. 530 Pg. 519-26 ( 2003) ISSN: 0065-2598 [Print] United States
PMID14562747 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Potassium Channels
  • Pinacidil
  • Glyburide
Topics
  • Animals
  • Glyburide (pharmacology)
  • Heart (drug effects)
  • In Vitro Techniques
  • Ion Channel Gating (drug effects)
  • Male
  • Myocardial Ischemia (prevention & control)
  • Pinacidil (pharmacology)
  • Potassium Channels (drug effects, physiology)
  • Rats
  • Rats, Wistar

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: